Etherscan Warns of 612% Surge in Address Poisoning Following the Ethereum Fusaka Upgrade

iconKuCoinFlash
Share
Share IconShare IconShare IconShare IconShare IconShare IconCopy
AI summary iconSummary

expand icon
Etherscan reported a 612% increase in address poisoning following the Ethereum network event known as the Fusaka upgrade on December 3, 2025. Between 2022 and 2024, 17 million attempts affected 1.3 million users, resulting in losses exceeding $79.3 million. Etherscan urged users to verify full addresses, use ENS domains, and enable the Address Highlight feature. The blockchain upgrade has heightened risks, prompting warnings to carefully check pop-up prompts when copying addresses.

BlockBeats report: On March 13, Etherscan posted on social media that Ethereum experienced approximately 17 million poisoning attempts between 2022 and 2024, affecting 1.3 million users and resulting in confirmed losses of at least $79.3 million. Following the Fusaka upgrade (December 3, 2025), transaction costs dropped significantly, causing a surge in dust transfers, which increased by 612%.


Etherscan recommends users take the following actions:

Always manually verify the full destination address before transferring (most important)

· Add private name tags to frequently used addresses + use ENS domains

Enable Etherscan Address Highlight feature

When copying the address, pay attention to the pop-up notification.

Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.